Company Snapshot: HGSI  Print This Story  Email This Story  Save this Link View PR Newswire's RSS Feed  Blogs Discussing this News Release  Search Blogs that Mention this News Release  Click this link to view linked Bookmarking Services Click this link to view linked Blogging Services


Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at UBS Conference

   Human Genome Sciences, Inc. logo. (PRNewsFoto/HUMAN GENOME SCIENCES, INC.)

ROCKVILLE, MD UNITED STATES
    ROCKVILLE, Md., Sept. 18 /PRNewswire-FirstCall/ -- Human Genome
Sciences, Inc. (Nasdaq: HGSI) announced today that its presentation at the
UBS Global Life Sciences Conference will be webcast and may be accessed at
http://www.hgsi.com

    (Logo: http://www.newscom.com/cgi-bin/prnh/20080416/HGSLOGO )

    A member of Human Genome Sciences' senior management team will present
a corporate overview on Monday, September 22, 2008 at 11:30 am Eastern
Time.

    Investors interested in listening to the live webcast should log on
before the start time in order to download any software required. The
archive of the webcast will be available for several days after the live
event.

    The mission of HGS is to apply great science and great medicine to
bring innovative drugs to patients with unmet medical needs.

    HGS and Human Genome Sciences are registered trademarks of Human Genome
Sciences, Inc. For additional information on Human Genome Sciences, Inc.,
visit the company's web site at http://www.hgsi.com.



SOURCE Human Genome Sciences, Inc.




Back to Topback to top

Related links:
  • http://www.hgsi.com
    Photo Notes:
    NewsCom: http://www.newscom.com/cgi-bin/prnh/20080416/HGSLOGO
    AP Archive: http://photoarchive.ap.org
    PRN Photo Desk, photodesk@prnewswire.com
  • http://www.prnewswire.com/comp/121115.html /
    CONTACT:
    Media, Jerry Parrott, Vice President,
    Corporate Communications, +1-301-315-2777, or Investor, Tim
    Barabe, Senior Vice President and Chief Financial Officer,
    +1-301-315-1780, both of Human Genome Sciences, Inc.